Stocks reversed yesterday’s slump, with all major US indexes rising. Megacap tech propelled stocks higher, with shares of every Mag 7 stock rising, except for Tesla

Your Evening Briefing

December 02, 2025

Megacap tech drives stocks higher; bitcoin rebounds

Stocks reversed yesterday’s slump, with all major US indexes rising. Megacap tech propelled stocks higher, with shares of every Mag 7 stock rising, except for Tesla. A rebound in bitcoin rippled across other speculative assets as the market’s mood shifted back to a risk-on sentiment. AI-linked stocks were generally higher as a hot new AI chip entered the villa when Amazon launched the Trainium3 during its AWS re:Invent 2025 event in Las Vegas.

Stocks that moved higher:

  • Intel powered its way to a fresh 52-week high on a boatload of bullish options demand and little fundamental news.
  • Oklo, Bloom Energy, and Plug Power surged as smaller, more speculative AI-linked energy plays are back in full boom mode, driven by a speculative bid in the options market.
  • Newly public electric aircraft maker Beta Technologies climbed after announcing it would supply a rival in the space, Embraer-funded Eve Air Mobility, with electric motors.
  • Shares of Boeing soared after the plane maker’s CFO said the company’s recovery “is in full force” and it expects positive free cash flow next year.
  • Shares of Dell rose after a $6.25 billion donation to fund investment accounts for children by the founder’s family was recognized in glowing terms by the president.
  • Credo Technology Group surged after the cable solutions provider, which makes many products used in AI data centers, delivered Q2 results that blew past Wall Street’s expectations. POET Technologies also rallied after Credo’s quarterly results showed immense demand for connectivity solutions.
  • MongoDB soared after a huge revenue and earnings beat.

Stocks that moved lower:

  • Advanced Micro Devices dipped after Amazon publicly launched its custom chip. Nvidia managed to end in the green, but significantly pared its gains after the announcement.
  • Bitcoin miner turned data center company IREN tumbled after Monday night’s announcement of plans to sell shares as part of a plan to refinance its debt.
  • Shares of Instacart fell after e-commerce giant Amazon outlined plans to test ultrafast delivery offerings in parts of Seattle and Philadelphia.
  • Ford ticked down as its EV sales tumbled more than 60% year over year on the end of the tax credit.
  • Signet Jewelers fell despite a Q3 earnings beat as holiday-quarter guidance disappointed investors.

Wall Street has great expectations for the next year in the stock market

Stock watchers are pretty bullish about the coming year — as they typically are — with eyes on the Fed and whether the AI boom will still have legs. BofA is a little skeptical. Read more.

Legendary short seller James Chanos on the problem with Strategy’s business model

The noise has grown louder about Strategy being in trouble, but most experts think Strategy can weather the current bitcoin downturn, though one critic predicts this is “the beginning of the end.”

Read more.

Tesla sales from its Shanghai plant jumped 10% in November, only the third time those sales have risen in a month this year, Bloomberg reports. These figures don’t break down what share of sales are within China — Tesla’s second-biggest market — or exported, but typically most made there are sold locally. Read more. 

  • OpenAI declares “code red” on Google three years after Google declared “code red” on OpenAI
    The tables have turned.
  • Apple retires AI head to show it’s serious about AI
    “This moment marks an exciting new chapter as Apple strengthens its commitment to shaping the future of AI for users everywhere.”
  • Amazon AWS and Google set up rare partnership as rivals try to prevent massive network outages
    The two cloud giants have created “a jointly engineered multicloud networking solution” that could help prevent wide-scale outages. 
  • Morgan Stanley upgrades Tempus AI to overweight
    As part of their reasoning, analysts spotlighted faster-than-expected growth in Tempus’ hereditary cancer risk testing business.
 

Was this email forwarded to you? Don’t miss out on future stories — subscribe to The Wrap and get your daily dose of financial news straight to your inbox. 

Craving more insights in your inbox? Subscribe to Chartr and Snacks for quality reads.

We care what you think! If you have any feedback or comments, feel free to reply and let us know your thoughts! 

InstagramTwitter
Sherwood Logo

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate... See more

Sherwood Terms and Conditions Our Editorial Standards Contact Us
Advertise With Us Unsubscribe Privacy Policy

SHERWOOD MEDIA, LLC, 85 Willow Road, Menlo Park, CA 94025